Page last updated: 2024-10-30

vitamin k 3 and alpha-Galactosidase A Deficiency

vitamin k 3 has been researched along with alpha-Galactosidase A Deficiency in 1 studies

Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CUNNINGHAM, RS2
KRAUEL, LH2

Other Studies

1 other study available for vitamin k 3 and alpha-Galactosidase A Deficiency

ArticleYear
Angiokeratoma corporis diffusum universale (Fabry); report of a case with symptomatic improvement on menadione.
    Northwest medicine, 1957, Volume: 56, Issue:2

    Topics: Angiokeratoma; Antifibrinolytic Agents; Fabry Disease; Heparin Antagonists; Humans; Naphthoquinones;

1957
Angiokeratoma corporis diffusum universale (Fabry); report of a case with symptomatic improvement on menadione.
    Northwest medicine, 1957, Volume: 56, Issue:2

    Topics: Angiokeratoma; Antifibrinolytic Agents; Fabry Disease; Heparin Antagonists; Humans; Naphthoquinones;

1957
Angiokeratoma corporis diffusum universale (Fabry); report of a case with symptomatic improvement on menadione.
    Northwest medicine, 1957, Volume: 56, Issue:2

    Topics: Angiokeratoma; Antifibrinolytic Agents; Fabry Disease; Heparin Antagonists; Humans; Naphthoquinones;

1957
Angiokeratoma corporis diffusum universale (Fabry); report of a case with symptomatic improvement on menadione.
    Northwest medicine, 1957, Volume: 56, Issue:2

    Topics: Angiokeratoma; Antifibrinolytic Agents; Fabry Disease; Heparin Antagonists; Humans; Naphthoquinones;

1957